Treatments targeting inotropy
Christoph Maack(Universitätsklinikum Würzburg), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Thomas Eschenhagen(Universität Hamburg), Frank Ruschitzka(Kantonsspital St. Gallen), Johann Bauersachs(Medizinische Hochschule Hannover), John G.F. Cleland(University of Glasgow), Piotr Ponikowski(Wroclaw Medical University), Frank R. Heinzel, Rudolf A. de Boer(Erasmus MC), Jean‐Luc Balligand(Cliniques Universitaires Saint-Luc), Joseph M. Metzger(University of Minnesota Medical Center), Lucie Carrier(Universität Hamburg), Zoltán Papp(University of Debrecen), Stefan Chłopicki(Jagiellonian University), Giuseppe Limongelli, Marco Metra(Vita-Salute San Raffaele University), Josep Masip, Veli‐Pekka Harjola(University of Helsinki), Carlo G. Tocchetti(Federico II University Hospital), Stéphane Heymans(Maastricht University Medical Centre), Denise Hilfiker‐Kleiner(Medizinische Hochschule Hannover), Alexander Dietl(University Hospital Regensburg), Lars H. Lund(Karolinska University Hospital), Wolfgang A. Linke(University Hospital Münster), Petar Seferović, Rodolphe Fischmeister(Inserm), Arsen Ristić(University of Belgrade), Hadi Skouri(University of Balamand), Dietmar J. Manstein(Medizinische Hochschule Hannover), Mehmet Birhan Yılmaz(Istanbul University-Cerrahpaşa), Gilles W. De Keulenaer(University of Antwerp), Stefan D. Anker(Charité - Universitätsmedizin Berlin), Dirk L. Brutsaert(ZNA Middelheim Hospital), Alexander R Lyon(Royal Brompton Hospital), Christian Mueller(Immutep (Germany)), Wolfram H. Zimmermann(Universitätsmedizin Göttingen), Nazha Hamdani(University Hospitals of the Ruhr-University of Bochum), Johannes Holzmeister(British Heart Foundation), Burkert Pieske(Berlin Institute of Health at Charité - Universitätsmedizin Berlin)
Cited by 227
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k